Gyre Therapeutics Inc.

NASDAQ: GYRE · Real-Time Price · USD
8.11
-0.11 (-1.34%)
At close: Aug 15, 2025, 3:59 PM
8.14
0.37%
After-hours: Aug 15, 2025, 04:04 PM EDT

Gyre Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
7.03M 9.99M 17.23M -34.86M -39.3M -46.31M -55.98M -44.24M -47.55M 6.55M -8.24M 11.88M -8.47M -80.03M -87.93M -86.51M -77.31M -74.63M
Depreciation & Amortization
2.07M 1.67M 1.56M 1.4M 1.03M 797K 375K 77K 54K 120K 230K 335K 380K 358K 290K 220K 177K 158K
Stock-Based Compensation
2.22M 1.33M 831K 7.54M 7.41M 7.48M 7.65M 621.28K 747.28K 1M 1.34M 1.77M 2.26M 2.89M 3.4M 3.64M 4M 3.85M
Other Working Capital
-1.96M -5.29M -4.02M -1.55M -2.03M -616.29K -5.09M -7.78M -3.88M -5.96M 1.41M -534.39K -3.22M 1.65M -1.51M -5.61M -6.83M -6M
Other Non-Cash Items
-1.24M -3.01M -7.09M 36.55M 48.36M 51.11M 50.79M 42.61M 30.77M -26.42M -21.48M -57.88M -59.99M 412K 1.99M -316K 4.67M 3.6M
Deferred Income Tax
-191K -288K -410K -410K -1.62M -1.47M -1.15M -1.15M 56K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-8.96M -16.35M -15.76M -7.74M -7.55M -258.31K 545.7K -523K -1.55M -8.56M -4.95M -6.35M -741K 5.13M 483K -5.54M -6.47M -3.99M
Operating Cash Flow
927K -6.65M -3.64M 2.48M 8.33M 11.36M 2.25M -2.58M -17.44M -27.26M -33.1M -49.3M -63.62M -71.45M -83.75M -88.19M -79.6M -74.61M
Capital Expenditures
-1.01M -2.21M -2.31M -4.76M -6.49M -6.87M -9.82M -4.87M -4.37M -5.1M -2.56M -5.48M -4.05M -1.82M -1.19M -878K -581K -250K
Cash Acquisitions
-50K -50K n/a 2.73M 5.51M 10.51M 11.46M 8.78M 6.05M 56.5M 55.5M 55.45M 55.45M n/a n/a n/a n/a n/a
Purchase of Investments
12.39M 5.35M -1.69M n/a -14.07M -10.2M -3.16M -5.79M -5.79M -55.5M -55.5M -52.87M -52.87M n/a n/a -5.89M -50.55M -91.62M
Sales Maturities Of Investments
n/a n/a n/a n/a n/a 5M 5M 7.5M 7.5M 57.5M 60.01M 60.37M 67.9M 23.95M 49.03M 79.64M 95.7M 101.69M
Other Investing Acitivies
-16.8M -13.79M -15.88M -16.63M -217.85K -640.85K 1.94M 622.95K 520.68K -54.27M -62.48M -57.16M -50.22M 15.83M 49.03M 73.75M 45.15M 10.07M
Investing Cash Flow
-5.47M -10.7M -19.88M -18.66M -15.27M -2.2M 5.43M 6.26M 3.92M 52M 54.09M 56.91M 65.28M 23.11M 48.19M 72.87M 44.57M 9.82M
Debt Repayment
n/a n/a n/a n/a n/a n/a -134.27K -134.27K -134.27K -134.27K n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -4K -4K -4K -79K -75K
Dividend Paid
n/a n/a n/a n/a -1.5M -5M -12.76M -57.8M -101.33M -97.83M -90.06M -45.03M n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
21.81M -657K -536K 1.22M 1.27M 1.25M 1.39M 45.15M 127.01K 136.79K 528.00 -45.15M -121.56K n/a n/a 435K 435K 435K
Financial Cash Flow
24.98M 2.79M 2.1M 2.52M 720.4K -2.94M -11.36M -12.72M -56.27M -52.89M -45.12M -45.13M -7.56K 110K 49.55M 49.55M 49.38M 77.47M
Net Cash Flow
20.39M -14.74M -21.7M -13.16M -10.57M 1.94M -7.9M -13.81M -68.47M -26.72M -22.68M -36.07M 1.77M -48.23M 13.99M 34.23M 14.35M 12.68M
Free Cash Flow
-79K -8.86M -5.96M -1.61M -8.29M -5.65M -17.69M -18.25M -21.8M -32.36M -35.66M -54.78M -67.67M -73.27M -84.94M -89.07M -80.18M -74.86M